Call Us
+919016820285
Contact Us For Help
Products

Sofosbuvir 400mg and Ledipasvir 90mg tablets

Sofosbuvir 400mg and Ledipasvir 90mg tablets

Product Details:

  • Drug Type Other Types
  • Physical Form Tablets
  • Dosage As Directed By Physician.
  • Dosage Guidelines As Directed By Physician.
  • Suitable For Adults
  • Storage Instructions Store in a cool and dark place.
  • Supply Ability : 1000000 Box Per Month
167.77 USD ($)
X

Price And Quantity

  • 167.77 USD ($)
  • As required by client. Box

Product Specifications

  • Other Types
  • Adults
  • Tablets
  • As Directed By Physician.
  • Store in a cool and dark place.
  • As Directed By Physician.

Trade Information

  • Hazira / Nhava Sheva
  • Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)
  • 1000000 Box Per Month
  • 1-2 Week
  • Yes
  • If order is confirmed we will reimburse the sample cost
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • WHO-GMP/ GMP/ COA/ As Required By Client

Product Description

Product Details:

Brand

LEDVICLEAR

 


We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of LEDVICLEAR TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

COMPOSITION :

LEDVICLEAR TABLET  (Sofosbuvir 400mg + Ledipasvir 90mg )
  • Brand name: LEDVICLEAR
  • Active Ingredients(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
  • Company Name: Abbott India
  • Strength : 400 mg + 90 mg
  • Package: 28 tabs
  • Pack Type: Bottle
Indication:

LEDVICLEAR Contain Sofosbuvir and Ledipasvir For the treatment of Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
  • The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
  • Globally, between 130-150 million people globally have chronic hepatitis C infection.
  • A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
  • There is currently no vaccine for hepatitis C; however, research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
  • injecting drug use through the sharing of injection equipment;
  • the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
  • the transfusion of unscreened blood and blood products.
Uses:-

Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Available other Brand: HEPCINAT LP, LEDIFOS, RESOF L, MYHEP LVIR, HEPCVIR L, SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOCRUZ LP, SOFOKEM L, CIMIVIR L


SALVAVIDAS PHARMACEUTICAL PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.